CN110063946A - A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun - Google Patents

A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun Download PDF

Info

Publication number
CN110063946A
CN110063946A CN201910312014.XA CN201910312014A CN110063946A CN 110063946 A CN110063946 A CN 110063946A CN 201910312014 A CN201910312014 A CN 201910312014A CN 110063946 A CN110063946 A CN 110063946A
Authority
CN
China
Prior art keywords
solution
buddhist nun
chitosan
sodium alginate
micro ball
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910312014.XA
Other languages
Chinese (zh)
Inventor
陈星羽
宋可可
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest Jiaotong University
Original Assignee
Southwest Jiaotong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest Jiaotong University filed Critical Southwest Jiaotong University
Priority to CN201910312014.XA priority Critical patent/CN110063946A/en
Publication of CN110063946A publication Critical patent/CN110063946A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of chitosan sodium alginate micro ball preparation method and applications for containing Ah pa and replacing Buddhist nun, the following steps are included: step 1: the alginate solution that the Ah pa of 10mg/mL is 0.0315% for Buddhist nun's solution, mass concentration being uniformly mixed according to the ratio that volume ratio is 1:23.5, obtains mixed solution A;Step 2: the calcium chloride solution that mass concentration is 0.2% being instilled in the mixed solution A that step 1 is prepared with the speed of 0.1ml/min, while stirring to get mixed solution B;Wherein mixed solution A and calcium chloride solution volume ratio are 24.5:1.5;Step 3: the chitosan solution that mass concentration is 0.07% being instilled in mixed solution B with the speed of 0.1ml/min, sufficiently after reaction, the required chitosan sodium alginate micro ball for containing Ah pa and replacing Buddhist nun is can be obtained in centrifugation, washing, vacuum freeze drying;The mixed solution B and chitosan solution volume ratio are 13:1;Microballoon of the present invention can promote drug in the absorption of enteron aisle;The absorption rate for improving drug can reduce the amount of being orally ingested of drug, reduce the side effect of drug bring.

Description

A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun
Technical field
The present invention relates to the preparations of sustained release agent, and in particular to a kind of chitosan sodium alginate micro ball system for containing Ah pa and replacing Buddhist nun Preparation Method and application.
Background technique
A Pa is used as a kind of oral preparation for Buddhist nun (methanesulfonic acid Ah pa replaces Buddhist nun's piece), has treatment late gastric cancer, can extend trouble The effect of the time-to-live of person;The ATP-binding site of the intracellular VEGFR-2 of its high competition has and blocks downstream signal transduction, Inhibit the effect of tumor tissues new vascular generation.But since gastrointestinal tract rate is very fast, damage etc. of the gastric environment to drug Cause human body few to drug absorption;It is 750mg that clinically Ah pa, which replaces everyone daily intake of Buddhist nun, at present, but this dosage is to trouble Person causes the adverse reactions such as hypertension, albuminuria, hand-foot syndrome, influences recovery effects.Existing oral Ah pa for Buddhist nun due to Destruction is absorbed in gastric environment, it is difficult to also possess curative effect of medication when reaching intestines environment, have office when treating intestines Cancerous disease It is sex-limited;And Ah pa is at high cost for Buddhist nun, and daily higher intake will cause the financial burden of patient.
Summary of the invention
The present invention provide it is a kind of there is slow releasing function, Small side effects, can targeted therapy intestinal cancer the shell for containing Ah pa and replacing Buddhist nun Glycan sodium alginate micro ball preparation method and application.
The technical solution adopted by the present invention is that: a kind of chitosan sodium alginate micro ball preparation method for containing Ah pa and replacing Buddhist nun, The following steps are included:
Step 1: being according to volume ratio by the alginate solution that the Ah pa of 10mg/mL is 0.0315% for Buddhist nun's solution, mass concentration The ratio of 1:23.5 is uniformly mixed, and obtains mixed solution A;
Step 2: the calcium chloride solution that mass concentration is 0.2% is mixed with what the speed instillation step 1 of 0.1ml/min was prepared It closes in solution A, while stirring to get mixed solution B;Wherein mixed solution A and calcium chloride solution volume ratio are 24.5:1.5;
Step 3: the chitosan solution that mass concentration is 0.07% being instilled in mixed solution B with the speed of 0.1ml/min, sufficiently After reaction, the required chitosan sodium alginate micro ball for containing Ah pa and replacing Buddhist nun is can be obtained in centrifugation, washing, vacuum freeze drying;Institute It states mixed solution B and chitosan solution volume ratio is 13:1.
Further, in the chitosan solution, contain 1% acetic acid.
Further, chitosan solution stands 30min after being added dropwise in the step 3, is then centrifuged.
Further, 20min is centrifuged under the conditions of 12000 r/min in the step 3, and in triplicate.
Ah pa is contained for the application of the chitosan sodium alginate micro ball of Buddhist nun, the microballoon is used to prepare treatment intestines cancer Targeted drug.
Further, the drug is oral preparation.
Further, the oral preparation it is one in containing Ah pa replace Buddhist nun 2mg.
The beneficial effects of the present invention are:
(1) the chitosan sodium alginate micro ball that the present invention is prepared can protect Ah pa not destroyed by gastric environment for Buddhist nun, promote medicine Object achievees the effect that targeted therapy intestinal cancer in the absorption of enteron aisle;
(2) the chitosan sodium alginate micro ball that the present invention is prepared has pH sensibility, and the target area for improving drug absorbs Utilization rate;
(3) the chitosan sodium alginate micro ball that the present invention is prepared can reduce the amount of being orally ingested of drug, reduce the financial burden, Reduce the side effect of drug bring.
Detailed description of the invention
Fig. 1 is the absorbance figure that various concentration Ah pa replaces Buddhist nun's standard solution.
Fig. 2 is that the Ah pa that contains that the embodiment of the present invention is prepared replaces the chitosan sodium alginate micro ball of Buddhist nun in human body Drug release patterns.
Specific embodiment
The present invention will be further described in the following with reference to the drawings and specific embodiments.
It prepares in accordance with the following methods and contains the chitosan sodium alginate micro ball that Ah pa replaces Buddhist nun, comprising the following steps:
Step 1: preparing the alginate solution that mass concentration is 0.0315%, be 0.07 wt% of 1% acetic acid containing mass concentration Chitosan solution;It is respectively that two kinds of solution magnetic stirrer over night are spare;
Step 2: the Ah pa that compound concentration is 10 mg/mL replaces Buddhist nun's solution, and 10 mg Ah pas are dissolved in 1ml methanol solution for Buddhist nun; It prepares obtained alginate solution with 23.5 ml steps 1 to mix, ultrasound is evenly dispersed to obtain mixed solution;
Step 3: the CaCl for being 0.2 wt% by 1.5 ml concentration using micro-injection pump2Solution is infused with the speed of 0.1 ml/min Enter in the mixed solution obtained to step 2, while magnetic agitation;
Step 4: in the mixed solution that the step 3 that 2 ml chitosan solutions instill magnetic agitation is obtained, rate is 0.1 ml/ Min stands 30 min after being added dropwise to complete;12000 r/min high speed centrifugation, 20 min removes supernatant, milli-Q water microballoon; After in triplicate, vacuum freeze drying is saved, and obtains the Ah pa that chitosan sodium alginate contains for Buddhist nun's Nano medication microsphere powder.
After tested according to the method described above, the chitosan sodium alginate being prepared contains Ah pa for the drugloading rate of Buddhist nun's microballoon 20%~25%.
It takes pictures through SEM, it can be seen that chitosan sodium alginate micro ball pattern, about 500 nm of microsphere diameter, hollow spherical cavity; Microsphere diameter varies slightly after carrying medicine, and drug is present in inside spherical cavity.
A Pa replaces the concentration standard curve of Buddhist nun's drug as shown in Figure 1, preparing mass concentration respectively is 0.005 wt%, 0.01 Wt%, 0.015 wt%, 0.02 wt%, 0.025 wt%, 0.03 wt%, 0.035 wt%, the Ah pa of 0.04 wt% are molten for Buddhist nun's standard Liquid, methanol are solvent;Using microplate reader detection characteristic wavelength be 348 nm at each strength solution absorbance value, obtain Ah Pa replaces the drug concentration standard curve of Buddhist nun.
It is 1.2 by the pH that the powder microballoon after freeze-drying that portion is obtained according to above-mentioned preparation method is dissolved in 10 ml In hydrochloric acid solution, drug simulated gastrointestinal environment extracorporeal releasing experiment is carried out.Delivery systme is put into 37 degree of shaking tables, 100 times/ Min, 20 mm of amplitude;System centrifuging and taking supernatant is detected into absorbance value at interval of 1 hour.
After release 4 hours, the microballoon being centrifuged is dissolved in the phosphate buffer that the pH of 10 ml is 7.4, simulates intestines Liquid Environment release;It is discharged in same shaking table, sampling in each hour is primary, after release, utilizes microplate reader test sample Chinese medicine Object Ah pa replaces the concentration of Buddhist nun, prepares In-vitro release curves (as shown in Figure 2).
From figure 2 it can be seen that medicine microspheres rest on stomach, and burst size is less 1~4 hour oral;In medication 5 Hour or so, medicine microspheres enter intestines environment, start a large amount of releases, drug release top occur at 8~9 hours;At this time Drug substantially completely discharges, and is combined with enterocyte, plays curative effect of medication.
Cytotoxicity, the suppression of degradation rate and Human umbilical vein endothelial cells are carried out to drug bearing microsphere made from above-mentioned experiment Ability processed is detected.Chitosan sodium alginate micro ball, which contains Ah pa, reduces the cytotoxicity of drug alone for Buddhist nun's microballoon, and It can finally be degraded and absorbed, the growth of Human Umbilical Vein Endothelial Cells is inhibited.Illustrate the nanosphere of chitosan sodium alginate The absorbability of drug and the toxicity to human body are only changed, it to be a kind of effective medicine that there is no the intrinsic effects for changing drug Object contains mode.
Chitosan sodium alginate micro ball can protect drug and not destroyed by gastric environment, while have good biocompatibility Can smooth degradation in vivo, drug can also be promoted in the absorption of enteron aisle, improve biological utilisation of drug during release Rate.Chitosan sodium alginate micro ball has pH sensibility, can be improved the absorption rate of oral drugs.Chitosan sodium alginate Microballoon is with the following functions as a kind of positively charged nanosphere:
(1) positively charged nanosphere in conjunction with electronegative enterocyte, can increase the intestines residence time of medicine microspheres;
(2) under acidic environment, chitosan sodium alginate micro ball swelling slows down, in conjunction with more closely, formed gel, prevent it from taking The drug release of band;The nanosphere Fast-swelling under neutral and acidic environment, surface is loose and rough porous, promotes drug Quick release;
(3) chitosan sodium alginate micro ball can be by the microorganism decomposition in small intestine, good biocompatibility, and hypotoxicity.
The present invention combines the medicament slow-release microsphere for containing Ah pa and replacing Buddhist nun using chitosan and sodium alginate, is used for intestines cancer Target therapeutic agent.When medicine microspheres can enter gastric acid environment after oral administration (pH is about 1.2), microballoon is due to pH sensibility And combining becomes close, and drug Ah pa is prevented to replace the release of Buddhist nun.When medicine microspheres are in digestion to intestines environment (pH is about 7.4), Microballoon breakdown releases drug achievees the purpose that control release time.Microsphere surface and enterocyte carry out charge bonded, can promote Enterocyte absorption of drugs increases the utilization efficiency of drug, reduces oral drugs and takes in dosage.
Existing to contain Ah pa for Buddhist nun's microballoon, mostly polymeric microballoon contains Ah pa for Buddhist nun's microballoon, this microballoon is used In intravenous injection, only have the function of that slow release Ah pa replaces Buddhist nun, the characteristic without medicament selection Environment release;The present invention prolongs It has grown Ah pa and has replaced Buddhist nun's drug residence time in vivo, haved the function that slow release, reduce the amount of being orally ingested of drug, drop Its low bring side effect;Gastric environment absorption of drugs is reduced, so that drug is mainly reached intestines position, reaches targeted therapy intestines The effect of cancer.

Claims (7)

1. a kind of chitosan sodium alginate micro ball preparation method for containing Ah pa and replacing Buddhist nun, which comprises the following steps:
Step 1: by the Ah pa of 10mg/mL for Buddhist nun's solution, mass concentration be 0.0315% alginate solution according to volume ratio It is uniformly mixed for the ratio of 1:23.5, obtains mixed solution A;
Step 2: the calcium chloride solution that mass concentration is 0.2% is mixed with what the speed instillation step 1 of 0.1ml/min was prepared It closes in solution A, while stirring to get mixed solution B;Wherein mixed solution A and calcium chloride solution volume ratio are 24.5:1.5;
Step 3: the chitosan solution that mass concentration is 0.07% being instilled in mixed solution B with the speed of 0.1ml/min, sufficiently After reaction, the required chitosan sodium alginate micro ball for containing Ah pa and replacing Buddhist nun is can be obtained in centrifugation, washing, vacuum freeze drying;Institute It states mixed solution B and chitosan solution volume ratio is 13:1.
2. a kind of chitosan sodium alginate micro ball preparation method for containing Ah pa and replacing Buddhist nun, feature exist according to claim 1 In containing 1% acetic acid in the chitosan solution.
3. a kind of chitosan sodium alginate micro ball preparation method for containing Ah pa and replacing Buddhist nun according to claim 1, feature It is, chitosan solution stands 30min in the step 3 after being added dropwise, and is then centrifuged.
4. a kind of chitosan sodium alginate micro ball preparation method for containing Ah pa and replacing Buddhist nun according to claim 1, feature It is, is centrifuged 20min in the step 3 under the conditions of 12000r/min, and in triplicate.
5. what is be prepared as described in claim 1-4 contains Ah pa for the application of the chitosan sodium alginate micro ball of Buddhist nun, spy Sign is that the microballoon is used to prepare the targeted drug for the treatment of intestines cancer.
6. application according to claim 5, which is characterized in that the drug is oral preparation.
7. application according to claim 6, which is characterized in that replace Buddhist nun 2mg containing Ah pa during the oral preparation is one.
CN201910312014.XA 2019-04-18 2019-04-18 A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun Pending CN110063946A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910312014.XA CN110063946A (en) 2019-04-18 2019-04-18 A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910312014.XA CN110063946A (en) 2019-04-18 2019-04-18 A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun

Publications (1)

Publication Number Publication Date
CN110063946A true CN110063946A (en) 2019-07-30

Family

ID=67367994

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910312014.XA Pending CN110063946A (en) 2019-04-18 2019-04-18 A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun

Country Status (1)

Country Link
CN (1) CN110063946A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114948911A (en) * 2022-06-17 2022-08-30 佛山市中医院 Traumatology oil sustained-release microcapsule and preparation method thereof
CN115057741A (en) * 2022-07-04 2022-09-16 西南交通大学 Preparation method of calcium alginate-chitosan microbead slow-release fertilizer difficult to swell

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1745848A (en) * 2005-07-29 2006-03-15 中国人民解放军第三军医大学 Chitin-sodium alginate packed pylorus helicobacterium protein microballs and their preparation
US20090162440A1 (en) * 2007-12-19 2009-06-25 Beijing Shengyiyao Science & Technology Development Co., Ltd. Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof
CN108354902A (en) * 2018-05-22 2018-08-03 杭州市肿瘤医院 A kind of Ah pa is for Buddhist nun's polymer micelle and preparation method thereof
CN109381436A (en) * 2017-08-14 2019-02-26 江苏恒瑞医药股份有限公司 A Pa is for Buddhist nun's pharmaceutical composition and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1745848A (en) * 2005-07-29 2006-03-15 中国人民解放军第三军医大学 Chitin-sodium alginate packed pylorus helicobacterium protein microballs and their preparation
US20090162440A1 (en) * 2007-12-19 2009-06-25 Beijing Shengyiyao Science & Technology Development Co., Ltd. Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof
CN109381436A (en) * 2017-08-14 2019-02-26 江苏恒瑞医药股份有限公司 A Pa is for Buddhist nun's pharmaceutical composition and preparation method thereof
CN108354902A (en) * 2018-05-22 2018-08-03 杭州市肿瘤医院 A kind of Ah pa is for Buddhist nun's polymer micelle and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Y. DAI, ET AL,.: "pH-responsive carboxymethyl chitosan-derived micelles as apatinib carriers for effective anti-angiogenesis activity: Preparation and in vitro evaluation", 《CARBOHYDRATE POLYMERS》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114948911A (en) * 2022-06-17 2022-08-30 佛山市中医院 Traumatology oil sustained-release microcapsule and preparation method thereof
CN114948911B (en) * 2022-06-17 2024-02-09 佛山市中医院 Wound oil slow-release microcapsule and preparation method thereof
CN115057741A (en) * 2022-07-04 2022-09-16 西南交通大学 Preparation method of calcium alginate-chitosan microbead slow-release fertilizer difficult to swell
CN115057741B (en) * 2022-07-04 2023-06-20 西南交通大学 Preparation method of calcium alginate-chitosan microsphere slow-release fertilizer not easy to swell

Similar Documents

Publication Publication Date Title
Li et al. Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges
Khotimchenko Pectin polymers for colon-targeted antitumor drug delivery
JP5175017B2 (en) Particulate carrier for improving oral absorption of active ingredients
de Souza et al. Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems
JP4234803B2 (en) Pharmaceutical composition with controlled drug release rate
KR20030012742A (en) Embolic materials comprising of chitin and/or chitosan and preparing method thereof
CN110063946A (en) A kind of chitosan sodium alginate micro ball preparation method and application for containing Ah pa and replacing Buddhist nun
CN103520207A (en) Targeting cisplatin sodium nano-alginate liposome
Nikolaev et al. Carbon adsorbents in oncology: achievements and perspectives
CN104323985B (en) A kind of preparation method of polysaccharide oral colon-target aqueous gel based on carbon material and application
CN107722304A (en) Thixotroping oxycellulose solution and its medical applications
CN101352423B (en) Omeprazole sodium lyophilized preparation
CN107158404A (en) It is a kind of applied to Liver targeting pH sensitivity nanoparticles delivery systems of chemotherapy of hepatocellular carcinoma administering drug combinations and preparation method thereof
EP1982703A2 (en) A transpulmonary composition
CN107362354A (en) A kind of oral insulin nanometer formulation and preparation method thereof
CN115337272B (en) Natural polysaccharide-based chemical-physical double-crosslinked hydrogel particles and preparation and application thereof
CN104324032B (en) Antituberculotics three compound recipe microsphere vascular targeting thromboembolism slow releasing agent and its production and use
CN101502490B (en) Ketoprofen bioadhesive gel microsphere and preparation method thereof
CN103664936A (en) Compounds for treating traumatic brain injury diseases and application thereof
CN109662956A (en) A kind of application of the chitosan drug-loading nano particle of oleanolic acid grafting
CN106421807A (en) Preparation method of insulin-supporting carboxymethyl chitosan/chitosan nanometer preparation
CN107823178B (en) Niflumic acid colon targeted preparation for treating irritable bowel syndrome and preparation method thereof
CN102670611B (en) Vascular targeting embolism sustained release agent of triple compound microsphere for antituberculosis drug, preparation method and applications thereof
CN114522139A (en) Herbal anti-inflammatory transdermal absorption microemulsion gel and preparation method thereof
CN100560060C (en) Nano-grade medicine microball and manufacture method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190730

RJ01 Rejection of invention patent application after publication